Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage

@article{Sen2003TripleHTI,
  title={Triple-H therapy in the management of aneurysmal subarachnoid haemorrhage},
  author={J. Sen and A. Belli and H. Albon and Laleh Morgan and N. Kitchen},
  journal={The Lancet Neurology},
  year={2003},
  volume={2},
  pages={614-621}
}
  • J. Sen, A. Belli, +2 authors N. Kitchen
  • Published 2003
  • Medicine
  • The Lancet Neurology
  • Cerebral vasospasm is a recognised but poorly understood complication for many patients who have aneurysmal subarachnoid haemorrhage and can lead to delayed ischaemic neurological deficit (stroke). Morbidity and mortality rates for vasospasm are high despite improvements in management. Since the middle of the 1970s, much has been written about the treatment of cerebral vasospasm. Hypervolaemia, hypertension, and haemodilution (triple-H) therapy in an intensive-care setting has been shown in… CONTINUE READING
    Update on subarachnoid haemorrhage
    • 72
    • PDF
    "Triple h" therapy for aneurysmal subarachnoid haemorrhage: real therapy or chasing numbers?
    • 13
    • PDF

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 67 REFERENCES
    Cerebral vasospasm after SAH
    • 1